Northam Weston T, Slingerland Anna L, Orbach Darren B, Smith Edward R
Department of Neurosurgery, Boston Children's Hospital, Boston, Massachusetts, USA.
Department of Radiology, Boston Children's Hospital, Boston, Massachusetts, USA.
Neurosurgery. 2023 Jun 1;92(6):1243-1248. doi: 10.1227/neu.0000000000002357. Epub 2023 Feb 6.
Digital subtraction angiography (DSA) assesses revascularization in pediatric moyamoya patients after surgery, but MRI and angiography (MRI/A) may provide comparable data.
To evaluate DSA and MRI/A with respect to clinical utility in postoperative follow-up, complication profile, and relative cost at 1 year.
All pediatric moyamoya patients who received bilateral indirect revascularization between 2011 and 2020 were retrospectively reviewed at 1 institution. Patients who underwent MRI/A-only, DSA-only, or both after 1 year were compared.
Eighty-two patients were included. At 1 year, patients who underwent either MRI/A (n = 29) or DSA (n = 40) had no significant differences in detection rate of new at-risk hypovascular territories (6.9% vs 2.5%, P = .568) or need for subsequent revascularization beyond the mean 40 ± 24-month follow-up period (3.4% vs 5.0%, P > .9). Among patients who underwent both MRI/A and DSA (n = 13), both studies identified the same at-risk territories. No patients experienced MRI/A-related complications, compared with 3 minor DSA-related complications. The use of MRI/A yielded a 6.5-fold reduction in cost per study vs DSA at 1 year.
Using DSA to follow moyamoya patients after indirect revascularization is generally safe but associated with a low rate of minor complications and a 6.5-fold greater financial cost relative to MRI/A. These data support changing practice to eliminate the use of DSA when following routine bilateral moyamoya cases in the absence of clinical symptoms or specific concerns. Using MRI/A as the primary postoperative follow-up modality in this select population provides noninferior care and greater patient access, while reducing cost and potentially decreasing risk.
数字减影血管造影(DSA)用于评估小儿烟雾病患者术后的血管重建情况,但磁共振成像和血管造影(MRI/A)可能提供类似的数据。
评估DSA和MRI/A在术后随访中的临床效用、并发症情况及1年时的相对成本。
对2011年至2020年间在1家机构接受双侧间接血管重建术的所有小儿烟雾病患者进行回顾性研究。比较术后1年时仅接受MRI/A、仅接受DSA或两者均接受的患者。
纳入82例患者。1年时,接受MRI/A(n = 29)或DSA(n = 40)的患者在新的高危低灌注区域检测率(6.9%对2.5%,P = 0.568)或在平均40±24个月的随访期后需要后续血管重建的情况(3.4%对5.0%,P>.9)方面无显著差异。在同时接受MRI/A和DSA的患者(n = 13)中,两项研究均识别出相同的高危区域。没有患者发生与MRI/A相关的并发症,而与DSA相关的轻微并发症有3例。与DSA相比,1年时使用MRI/A每次检查的成本降低了6.5倍。
间接血管重建术后使用DSA随访烟雾病患者总体安全,但轻微并发症发生率较低,且相对于MRI/A,财务成本高6.5倍。这些数据支持改变做法,在无临床症状或特殊担忧的情况下,对常规双侧烟雾病病例进行随访时不再使用DSA。在这一特定人群中,将MRI/A作为主要的术后随访方式可提供非劣效的护理,增加患者可及性,同时降低成本并可能降低风险。